AmerisourceBergen reorganizes management
VALLEY FORGE, Pa. Drug distribution and health services giant AmerisourceBergen Corp. today announced a major restructuring of its operations.
The result, said company spokesman Michael Kilpatric, will be a “more streamlined organizational structure designed to drive increased efficiency and effectiveness.”
In line with the changes, Terry Haas, ABC executive vice president and chief integration officer, has left the company “to pursue other interests,” according to the company. ABC president and chief executive officer R. David Yost praised Haas for his “extraordinary contribution to AmerisourceBergen,” as well as the major role he played in the integration of Amerisource and Bergen Brunswig following their merger.
Yost explained the restructuring as follows: “To continue meeting the challenges of an ever changing pharmaceutical environment, AmerisourceBergen needs the infrastructure and cost structure that allows the Company to compete as the most efficient and effective operating company in our industry. It is with that singular focus that we are further integrating our organization.”
The organizational changes are effective immediately. Among the management shifts underway:
- Michael DiCandilo, ABC executive vice president and chief financial officer, expands his duties with the added position of chief operating officer for AmerisourceBergen Drug Corp. (ABDC) and continues to report directly to Yost. The ABDC functions reporting to DiCandilo in his new role include Supply Chain Management; Operations—including the distribution network—and Financial Operations, which previously reported to him. Yost continues to lead ABDC and continues to have the executives leading sales and marketing reporting to him.
- Steven Collis, executive vice president of AmerisourceBergen and president of the ABC Specialty Group, also has an expanded role that now encompasses supervision of PMSI, the company’s workers’ compensation business. “Steve continues his responsibilities for helping shape the policy and strategy of ABC and for more closely integrating [the specialty group] across AmerisourceBergen,” the company noted. He continues to report directly to Yost.
- Thomas Murphy, senior vice president and chief information officer, will also take on additional duties by assuming leadership of Business Transformation, the company’s multi-year process improvement project, which includes design of an ERP (Enterprise Resource Planning) system for ABDC and the corporation. Yost continues his executive leadership of the overall improvement effort, while Murphy continues to report directly to DiCandilo.
Anthem BC/BS allows doctors to access EMRs via cell phone
MANCHESTER, N.H. Anthem Blue Cross and Blue Shield in New Hampshire has unveiled new technology that will enable physicians to have secure access to online patient medical records and claims information from their mobile phones.
“Now all licensed New Hampshire practitioners who are part of our e-prescribing program are also able to access both medical records and claims data on Anthem members, anytime, anywhere by using their web-enabled cell phone,” said Richard Lafleur, medical director, Anthem Blue Cross and Blue Shield in New Hampshire, who added that participants could also access the new program from their office or home computer.
The addition of the new technology, known as Member Medical History, further enhances the e-prescribing tool by delivering an unprecedented amount of clinical information to the physician wherever he or she may be. Now the doctor looking to generate an electronic prescription is able to quickly access their Anthem patient’s medical history, getting valuable information on medical conditions and the patient’s most recent care, test results, or diagnoses by other clinicians.
“Putting even more comprehensive information in the physician’s hands at the time care decisions are being made improves quality and efficiency,” said Charles Kennedy, vice president of health information technology for Anthem. “E-prescribing and MMH are good examples of how Anthem can use technology to create a community benefit for all patients while still delivering unique value for our members.”
Study shows metformin as effective as insulin injections during pregnancy
BOSTON According to a new study, metformin, the generic version of Bristol-Myers Squibb’s diabetes drug Glucophage, is just as effective as insulin injections in treating women who develop diabetes during pregnancy, researchers in New Zealand and Australia reported yesterday.
Gestational diabetes appears in 1-in-20 pregnant women, and there has been concern that metformin might affect a fetus because the drug can cross the placenta.
But the study, led by Janet Rowan of the Auckland City Hospital in New Zealand, found that the risk of complications such as respiratory distress, birth trauma and newborn hypoglycemia, or low blood sugar, was no different for the 363 women who received metformin and the 370 given conventional insulin shots.
After delivery, nearly 77 percent of the metformin recipients said they would want to stay with the pill if they developed diabetes during pregnancy again, even though 46 percent still needed supplemental insulin injections at some point. On the other hand, only 27 percent of those who got insulin shots felt the same way.
But doctors may still be cautious, the researchers said. “Clinicians may remain circumspect about using metformin until follow-up data for offspring are available,” they wrote. The children born during the study are being tested when they reach their second birthday.